Article (Scientific journals)
Le monoxyde d'azote exhale: un nouveau biomarqueur des pathologies respiratoires
HEINEN, Vincent; Claeys, Mathieu; Louis, Renaud
2006In Revue Médicale de Liège, 61 (1), p. 37-42
Peer reviewed
 

Files


Full Text
Le monoxyde d'azote exhalé_Heinen_06_RevMedLg.pdf
Publisher postprint (541.23 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] There has been a growing interest for exhaled biomarkers. We review studies examining NO as a potential marker of airway inflammation, enabling noninvasive repeated monitoring of airway inflammation. The measurement technique has been standardized. We have determined the local normal levels for the Liege region. The exhaled NO level is elevated in asthma, and can predict asthma exacerbation. Exhaled NO has a value for the diagnosis of cystic fibrosis and primary ciliary dyskinesia.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
HEINEN, Vincent 
Claeys, Mathieu ;  Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur
Louis, Renaud ;  Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Language :
French
Title :
Le monoxyde d'azote exhale: un nouveau biomarqueur des pathologies respiratoires
Alternative titles :
[en] Exhaled Nitric Oxide: A New Biomarker for Respiratory Pathologies
Publication date :
January 2006
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
61
Issue :
1
Pages :
37-42
Peer reviewed :
Peer reviewed
Available on ORBi :
since 06 March 2009

Statistics


Number of views
208 (1 by ULiège)
Number of downloads
449 (8 by ULiège)

Scopus citations®
 
7
Scopus citations®
without self-citations
3

Bibliography


Similar publications



Contact ORBi